AbstractObjectivesObjective: The purpose of this study is to investigate the treatment of herbal medicine for patients with COVID-19 asymptomatic infections.
MethodIn English, search engines such as ‘PubMed’, ‘Science Direct’, and ‘Cumulative Index to Nursing and Allied Health Literature (CINAHL)’ were used. In Chinese, search engines such as ‘China National Knowledge Infrastructure (CNKI)’ and Wanfang were used. The keywords for the search engines were ‘COVID-19’, ‘asymptomatic infection’, ‘Korean Medicine’, ‘traditional Chinese medicine’, ‘herbal medicine’, and etc. Only clinical studies using herbal medicine for patients without fever or respiratory symptoms were selected. We excluded the cases that do not fit the research topic.
ResultsA total of 5 studies were finally selected. Among them, four of them used integrated herbal medicine and Western medicine, and one of the studies treated exclusively for herbal medicine. There were a total of seven prescriptions for herbal medicine used in the study. Outcome variables were used as following: lab test, nucleic acid conversion time, hospitalization period, chest CT, and etc. In the RCT study, herbal medicine and Western medicine decreased nucleic acid conversion time, average hospitalization time compared to the control group, but it was not statistically significant. No other adverse reactions were reported in all studies.
ConclusionAccording to the results, integrated herbal medicine and Western medicine might be an effective treatment for patients with COVID-19 asymptomatic infection reducing hospitalization period, time of nucleic acid turning negative. No severe adverse effects were reported. However, it is thought that better-designed research will be needed in the future.
참고문헌1. Lee S, Kim T, Lee E, Lee C, Kim H, Rhee H, Park S, Son H, Yu S, Park J, Choo E, Park S, Loeb M, Kim T. Clinical course and molecular viral shedding among asymptomatic and symptomatic patients with SARS-CoV-2 infection in a community treatment center in the Republic of Korea. JAMA Intern Med. 2020; 180:11. 1–6. 10.1001/jamainternmed.2020.3862
2. Oran DP, Topol EJ. Prevalence of Asymptomatic SARS-CoV-2 Infection - A Narrative Review. Ann Intern Med. 2020; 173:5. 362–367. 10.7326/M20-3012
3. Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, Fan Y, Zheng C. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020; 20:425–434. 10.1016/S1473-3099(20)30086-4
4. Lee D, Kim Y, Lee H, Hwang H, Nam S, Kim J. The influence of public fear, and psycho-social experiences during the coronavirus disease 2019 (COVID-19) pandemic on depression and anxiety in South Korea. Kor J Counsel Psychoth. 2020; 32:4. 2119–2156.
5. Chen P, Lee N, Cia C, Ko W, Hsueh P. A review of treatment of coronavirus disease 2019 (COVID-19): therapeutic repurposing and unmet clinical needs. Front Pharmacol. 2020; 11:58495610.3389/fphar.2020.584956
6. Gao Z, Xu Y, Sun C, Wang X, Guo Y, Qiu S, Ma K. A systematic review of asymptomatic infections with COVID-19. J Microbiol Immunol Infect. 2020; 10.1016/j.jmii.2020.05.001Epub ahead of print.
7. Jang I, Baik Y, Sun S, Lee J, Han C. An overview of the herbal remedies for severe acute respiratory syndrome (SARS) in WHO official report (2004). Korean J Orient Int Med. 2009; 30:3. 571–581. uci: G704-000999.2009. 30.3.014
8. Wang Y, Xue J, Dai E. Department of Internal Medicine, The Fifth Hospital of Shijiazhuang City, Hebei. Clinical study on the treatment of patients with novel coronavirus pneumonia and asymptomatic infection with integrated traditional Chinese and western medicine. Hebei J TCM. 2020; 42:05. 645–649. 10.3969/j.issn.1002-2619.2020.05.001
9. Xie X, Song Y, Ran C, Chen S, Wei D, Wang C, Zhou Z, Ran J, Xiang Y, Yu Z, Zhao Y, Luo X, Tao W, Li Y, Tang J, Liu H. Clinical research of Chaihu Ganlu Decoction on COVID-19 asymptomatic infected patients. JETCM. 2020; 29:11. 1888–1890. 10.3969/j.issn.1004-745X.2020.11.003
10. Luo X, Liu H, Xie X, Song Y, Ran C, Wei D, Chen S, Xiang Y, Zhao Y, Tang J. Clinical Observation on 50 cases of asymptomatic infected with COVID-19 by treatment of integrated of Traditional Chinese and Western Medicine. J Chengdu Univ of TCM. 2020; 43:04. 14–18. 10.13593/j.cnki.51-1501/r.2020.04.014
11. Chen S, Wei Y, Jiao Y, Li M. A case report on the treatment of a COVID-19 asymptomatic infected child. China’s Naturopathy. 2020; 28:14. 1–3. 10.19621/j.cnki.11-3555/r.2020.1401
12. Liu Q, Zhang Y, Long Y. A child infected with severe acute respiratory syndrome coronavirus 2 presenting with diarrhea without fever and cough: A case report. Medicine (Baltimore). 2020; 99:33. e2142710.1097/MD.0000000000021427
13. Cella L, Gagliardi G, Hedman M, Palma G. Injuries from asymptomatic COVID-19 disease: New hidden toxicity risk factors in thoracic radiation therapy. Int J Radiat Oncol Biol Phys. 2020; 108:2. 394–396. 10.1016/j.ijrobp.2020.06.055
14. Qiu J. Covert coronavirus infections could be seeding new outbreaks. Nature. 2020; 10.1038/d41586-020-00822-xEpub ahead of print.
15. Dalskov L, Møhlenberg M, Thyrsted J, Blay-Cadanet J, Poulsen ET, Folkersen BH, Skaarup SH, Olagnier D, Reinert L, Enghild JJ, Hoffmann HJ, Holm CK, Hartmann R. SARS-CoV-2 evades immune detection in alveolar macrophages. EMBO Rep. 2020; 21:12. e5125210.15252/embr.202051252
16. Han H, Xu Z, Cheng X, Zhong Y, Yuan L, Wang F, Li Y, Liu F, Jiang Y, Zhu C, Xia Y. Descriptive, retrospective study of the clinical characteristics of asymptomatic COVID-19 patients. mSphere. 2020; 5:5. e00922–20. 10.1128/mSphere.00922-20
17. Meyerowitz EA, Richterman A, Bogoch II, Low N, Cevik M. Towards an accurate and systematic characterisation of persistently asymptomatic infection with SARS-CoV-2. Lancet Infect Dis. 2020; S1473-3099(20)30837-9. 10.1016/S1473-3099(20)30837-9
18. Jang I, Hsing L, Han C. An overview on severe acute respiratory syndrome(SARS) in WHO clinical reports. Korean J Orient Int Med. 2005; 26:2. 440–452. uci: G704-000999. 2005.26.2.001
19. Korean Institute of Oriental Medicine. TCM treatment trend on COVID-19 in China. 2020; 25:88
20. Kim D, Chu H, Min B, Moon Y, Park S, Kim K, Park S, Kim Y, Song M, Choi G, Lee E. Telemedicine center of Korean Medicine for treating patients with COVID-19: a retrospective analysis. Integr Med Res. 2020; 9:3. 10049210.1016/j.imr.2020.100492
21. Ge H, Wang X, Yuan X, Xiao G, Wang C, Deng T, Yuan Q, Xiao X. The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis. 2020; 39:6. 1011–1019. 10.1007/s10096-020-03874-z
22. Dong Z, Lu X, Tong X, Dong Y, Tang L, Liu M. Forsythiae Fructus: A Review on its phytochemistry, quality control, pharmacology and pharmacokinetics. Molecules. 2017; 22:9. 146610.3390/molecules22091466
23. Chang H, Yeh C, Sheu F. A novel immunomodulatory protein from Poria cocos induces Toll-like receptor 4-dependent activation within mouse peritoneal macrophages. J Agric Food Chem. 2009; 57:14. 6129–39. 10.1021/jf9011399
24. Abe H, Sakaguchi M, Odashima S, Arichi S. Protective effect of saikosaponin-d isolated from Bupleurum falcatum L. on CCl4-induced liver injury in the rat. Naunyn Schmiedebergs Arch Pharmacol. 1982; 320:3. 266–71. 10.1007/BF00510139
25. Hattori T, Furuta K, Hayashi K, Nagamatsu T, Ito M, Suzuki Y. Studies on the antinephritic effects of plant components (6): antinephritic effects and mechanisms of phellodendrine (OB-5) on crescentic-type anti-GBM nephritis in rats (2). Jpn J Pharmacol. 1992; 60:3. 187–95. 10.1254/jjp.60.187
26. Jang M, Kim Y, Bae E, Oh T, Choi H, Lee J, Oh H, Lee S. Saikosaponin D isolated from Bupleurum falcatum inhibits selectin-mediated cell adhesion. Molecules. 2014; 19:12. 20340–9. 10.3390/molecules191220340
27. Ying Z, Li X, Dang H, Wang F, Xu X. Saikosaponin-d affects the differentiation, maturation and function of monocyte-derived dendritic cells. Exp Ther Med. 2014; 7:5. 1354–1358. 10.3892/etm.2014.1568
28. Ozaki Y, Rui J, Tang Y, Satake M. Antiinflammatory effect of Forsythia suspensa Vahl and its active fraction. Biol Pharm Bull. 1997; 20:8. 861–4. 10.1248/bpb.20.861
29. Ozaki Y, Rui J, Tang Y. Antiinflammatory effect of Forsythia suspensa V(AHL) and its active principle. Biol Pharm Bull. 2000; 23:3. 365–7. 10.1248/bpb.23.365
30. Abdel-Rahman MK. Can apricot kernels fatty acids delay the atrophied hepatocytes from progression to fibrosis in dimethylnitrosamine (DMN)-induced liver injury in rats? Lipids Health Dis. 2011; 10:11410.1186/1476-511X-10-114
31. Yurt B, Celik I. Hepatoprotective effect and antioxidant role of sun, sulphited-dried apricot (Prunus armeniaca L.) and its kernel against ethanol-induced oxidative stress in rats. Food Chem Toxicol. 2011; 49:2. 508–13. 10.1016/j.fct.2010.11.035
|
|